REYNOLDS MARK (CFO) purchased 38.4% of their position (2K shares) of GEOVAX LABS, INC. on the open market
Open‑market purchase worth $5.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/7/2024ACC: 0001437749-24-003380
+2K
Net shares
Net buyer
$5.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$2.77
Trade value
$5.54K
% of position
38.4%
2/7/2024
5.21K→7.21K
Total
Net shares
+2K
Net value
$5.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2024 | P · Purchase | +2K | $2.77 | $5.54K | 38.4% | 5.21K | 7.21K |
| Total | +2K | $5.54K | ||||||
Derivative Transactions0
No derivative transactions reported